Artificial Intelligence-assisted Colonoscopy With or Without Endocuff

Status Recruiting

Clinical Trial Summary

Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI) and Endocuff vision are promising new devices to improve the ADR. However, the effect of combining AI and Endocuff vision on ADR remains unclear. The aim of this prospective randomized study is to compare the ADR of AI plus Endocuff vision, AI alone and standard colonoscopy examination.

Clinical Trial Description

This is a prospective single-blinded randomized controlled trial of three different types of colonoscopy examinations by 1:1:1 ratio. We use EndoAim AI (ASUS, Taiwan) and Endocuff vision (Olympus, UK) assisted colonoscopy in the first group. We use AI assisted colonoscopy in the 2nd group. We use standard colonoscopy in the 3rd group. Eligible patients are older than 40 years old and receive colonoscopy for either symptomatic or screening/surveillance. All endoscopists should receive training on EndoAim AI systems and Endocuff vision. During the procedure, experienced endoscopists use high-definition endoscopes (EVIS-EXERA 290 video system, Olympus Optical, Aizu, Japan) under white light and insert to the cecum in the three different groups. The cecal intubation is confirmed by the identification of ileocecal valve and appendiceal orifice. The Boston Bowel Preparation Scale is used for grading the bowel preparation quality. The size (compared with biopsy forceps), location and morphology of polyps are recorded by the independent endoscopist. All polyps ae removed by either biopsy or polypectomy. The insertion and withdrawal time are measured. The time of the polypectomy site is not included in the withdrawal time. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05863208
Study type	Interventional
Source	E-DA Hospital
Contact	Ying Nan Tsai, MD
Phone	+88676150022
Email	littlepig9933@gmail.com
Status	Recruiting
Phase	N/A
Start date	May 2, 2023
Completion date	December 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03442738` - A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)
Completed	`NCT03041532` - Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening Programme	N/A
Not yet recruiting	`NCT05141773` - Artificial Intelligence Aid Systems and Endocuff in Colorectal Adenoma Detection	N/A
Completed	`NCT03137277` - A Study Between Two Instrument Generations to Improve Adenoma Detection in Screening Colonoscopy
Recruiting	`NCT05125939` - Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
Completed	`NCT04945044` - Artificial Intelligence Aid Systems in Colorectal Adenoma Detection	N/A
Completed	`NCT04472741` - Comparison of Newer Colonoscopy Devices With Standard Forward Viewing (SFV) Colonoscopes in Daily Practice	N/A
Recruiting	`NCT04963010` - Impact of SFV of Proximal Colon on ADR	N/A
Completed	`NCT04086706` - Retroflexion In The Ascending Colon Is A Costless Endoscopic Maneuver Increasing Adenoma Detection Rate
Not yet recruiting	`NCT03185299` - Impact of Reinforced Education by Video on the Quality of Bowel Preparation	N/A
Completed	`NCT02507037` - Effect of Gum Chewing on Bowel Cleansing Before Colonoscopy	Phase 4
Completed	`NCT02540239` - Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy	N/A
Completed	`NCT04397120` - The Factors Affecting ADR of Screening Colonoscopy
Completed	`NCT01786213` - Training Effects in Colonoscopy	N/A
Completed	`NCT06173297` - Assessing the Agreement Between Endoscopic and Histopathological Diagnosis of Colorectal Sessile Serrated Lesions.
Not yet recruiting	`NCT03352700` - Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy	Phase 4
Not yet recruiting	`NCT03356015` - Comparison Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation	Phase 4
Recruiting	`NCT04102631` - A Multicenter Study Evaluating the Effectiveness of Endo.Angel in Improving the Quality of Colonoscopy	N/A
Not yet recruiting	`NCT02832869` - Impact of Reinforced Education by Wechat and Short Message Service on the Quality of Bowel Preparation	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms